Integrated Biosciences

Integrated Biosciences is an emerging biotechnology company that has pioneered a novel approach combining synthetic biology and AI-driven small molecule drug discovery to develop next-generation therapies for age-related diseases. The company was founded in 2022 by Dr. Felix Wong and Dr. Max Wilson, scientists trained at MIT, Harvard University, and Princeton University.